Tamera is a Movies and TV Interview Editor for Collider. She mostly works behind the scenes for the site, and still can't believe she gets to write and edit for all the things she loves. In her free ...

Audiences who don't enjoy watching a good old-fashioned creature feature shouldn't check out Xeno. The coming-of-age sci-fi movie relies on the tropes of the adventure genre, but it also hides a ...

Producer Kevin Hart's new alien adventure drama movie features two sci-fi veterans in a film that is described as a “heartfelt adventure," described as "E.T. meets Alien." Per Collider, Xeno stars ...

Lance has been a freelance writer since 2021. He has a passion for all things fun and interesting. Whether movies, TV shows, anime, or games, so long as it catches his eye, you can be sure he'll spend ...

It's hard to make games. When you have absolutely no idea how to actually make a game, that might seem like a naive understatement, but we imagine it's true. Games today are massive, epic ventures; ...

Day (She/Her) is a massive RPG fan who has played most Square Enix, Monolithsoft, and Nintendo games. Her favorite series are Dragon Quest and Xeno. She also loves NieR, Pokemon, Zelda, and many other ...

Well, here's something you don't see every day! The arena shooter Xeno Crisis, which launched on the Switch eShop in 2019 (and has already been released on multiple retro platforms), is getting a ...

Geoffrey Martin is the dedicated Game Rant List Trainer. Geoffrey's gaming industry experience is quite extensive including working as a Video Producer for MojoPlays, doing regular Voiceovers for ...

Luna Guthrie is a Movie Features Editor for Collider, writer and film critic. She began as a writer for Collider in 2021 and joined the editorial team in 2024. She has a bachelor's degree in ...

Xeno Biosciences may have been unable to prove that its drug delivering oxygen to the gastrointestinal tract can induce weight loss, but LPOXY Therapeutics has penned a $7.5 million biobucks deal to ...

BOSTON, MA, Nov. 05, 2020 (GLOBE NEWSWIRE) -- XenoTherapeutics, a clinical-stage cell and gene therapy company engineering immune-compatible cells, tissues, and organs, has completed the first of two ...